Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Indee Labs Adopts Scispot to Operate as a Digital Biotech Company

Scispot, the creator of the best tech stack for modern biotech, announces its partnership with Indee Labs, the developer of Hydropore for non-viral intracellular delivery. This collaboration aims to empower Indee Labs to digitalize and centralize their research and development processes, leveraging Scispot’s no-code operating platform for enhanced efficiency, compliance, and automation, enabling them to operate as a true Digital Biotech company.

AiThority: How AI Can Improve Public Safety

Scispot unifies the core functionalities of Electronic Lab Notebook (ELN) and Laboratory Information Management System (LIMS) in a single platform while offering seamless one-click integrations with hundreds of 3rd-party apps and instruments. The platform streamlines repeatable workflows, automates redundant tasks, and generates valuable insights for improved R&D decisions. With Scispot, Indee Labs and other Scispot customers can efficiently meet stringent compliance requirements, such as HIPAA, SOC 2, and CFR Part 11, ensuring a secure and compliant research environment.

Indee Labs’ groundbreaking Hydropore™ platform enables non-viral intracellular delivery to modify mammalian T cells without viral vectors. Adopting Scispot’s tech stack allows Indee Labs to optimize their workflow and concentrate on advancing immune cell research. “We’re thrilled to partner with Indee Labs and support their innovative work in immunotherapy,” said Guru Singh, founder & CEO of Scispot. “Our platform’s automation, advanced analytics, and visualization tools will streamline workflows, improve data management, and propel scientific progress.”

“Scispot’s no-code digital operating platform will greatly streamline our R&D processes, enabling our team to focus on what truly matters – advancing immunotherapy research,” says Ryan Pawell, CEO of Indee Labs. “Not only does Scispot perfect our internal technical operations, but the seamless integration and automation capabilities offered by Scispot make it a lot easier to operate as a distributed biotech company.”

Related Posts
1 of 40,565

Read More: The Practical Applications of AI in Workplace

Indee Labs’ partnership with Scispot highlights their dedication to innovation and optimization across all aspects of research and development. Supported by funding from IndieBio/SOSV, Y Combinator, Social Capital, Founders Fund, and the National Institutes of Health, Indee Labs has attracted attention from top pharmaceutical companies, life science and biotechnology organizations, and renowned academic institutions such as UCSF, Medical University of South Carolina, and Stanford.

Scispot has become the preferred tech stack for modern biotech startups and scaleups worldwide. On a mission to transform biotech companies into Digital Biotechs, Scispot eliminates data silos, streamlines R&D, and automates processes. With hundreds of integrations, connectors for 3rd-party apps and instruments, and powerful data transformation and analytics capabilities, Scispot helps biotech companies accelerate scientific breakthroughs and bring innovations to market faster.

Latest Insights: What Techniques Will Deliver for Measuring Attention in 2023?

[To share your insights with us, please write to]

Comments are closed.